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A randomized trial of a telephone-delivered exercise intervention for non-urban 
dwelling women newly diagnosed with breast cancer: Exercise for Health-rural 
Manuscript Number: ABM-D-11-00077 
Abstract 
Background Physical activity is important following breast cancer. Trials of non-face- 
to-face interventions are needed to assist in reaching women living outside major 
metropolitan areas. 
Purpose To evaluate the feasibility and effectiveness of a telephone-delivered, mixed 
aerobic and resistance exercise intervention for non-urban Australian women with 
breast cancer. 
Methods A randomized controlled trial comparing an eight-month intervention 
delivered by Exercise Physiologists (Tel; n = 73) to usual care (UC; n = 70). 
Results 61% recruitment rate and 96% retention at 12 months; 79% of Tel group 
women received at least 75% of calls; odds (OR; 95% CI) of meeting intervention 
targets favored the Tel group for resistance training (OR 3.2; 1.2, 8.9) and aerobic (OR 
2.1; 0.8, 5.5) activity. 
Conclusions Given limited availability of physical activity programs for non-urban 
women with breast cancer, results provide strong support for feasibility and modest 
support for the efficacy of telephone-delivered interventions. 
Keywords: breast cancer, physical activity, behavior change intervention, 
telephone, rural, randomized trial 
1 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Background 
Breast cancer is the most common invasive cancer among Australian women, and with 
5-year survival rates reaching 88% (1), there are increasing numbers of breast cancer 
survivors needing support to enhance recovery and improve long-term quality of life 
outcomes (2). Rural women comprise one third of all Australian women with breast 
cancer, and their geographic location has been shown to negatively influence stage at 
diagnosis, access to cancer care, type of treatment and related outcomes (3). 
A large evidence base supports the ability of physical activity to enhance recovery both 
during and following breast cancer treatment (4, 5). Recent US cohort study findings 
suggest that post-diagnosis physical activity may also improve overall and cancer- 
specific survival (6-9). However, internationally and in Australia, most women with 
breast cancer engage in insufficient physical activity to reap health benefits (10, 11). 
As women live longer following a diagnosis of breast cancer, research needs to address 
means of supporting them to initiate and maintain physical activity. While many 
excellent breast cancer rehabilitation programs are offered in tertiary hospital settings, 
these are accessible only to women living in metropolitan areas (1, 3). Similarly, most 
physical activity trials in breast cancer have evaluated intensive clinic-based 
interventions involving face-to-face delivery (12). Thus, the extant evidence as yet 
provides limited guidance on how best to deliver such programs to women unable or 
unwilling to attend such programs, including those living outside metropolitan areas. 
Several trials have evaluated non-face-to-face intervention delivery methods, during 
(13-15) and after breast cancer treatment (16-20). All focussed on home-based aerobic 
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exercise and three included resistance training (13, 16, 17). Interventions were 
delivered via telephone following an initial face-to-face session (13-15, 18); via print 
materials (20); or, the combination (16, 17). While outcomes reported across trials 
varied considerably, the majority observed significant treatment effects for physical 
activity-related outcomes (i.e., aerobic capacity, physical function, meeting physical 
activity guidelines; 13, 15- 18) with a minority also reporting improvements in quality of 
life (17, 20). No studies specifically targeted non-urban women, despite the fact that 
non-face-to-face intervention delivery is particularly well-suited for this population 
subgroup. 
The telephone-delivered intervention model is particularly advantageous, as it can be 
adopted by existing telephone cancer support and information services and it provides 
an efficient, evidence-based referral source for busy clinicians. Our previous research 
on telephone-delivered lifestyle interventions in other chronic disease populations 
suggests that the telephone is an intervention delivery mechanism that can promote 
both initiation (21, 22) and maintenance of health behavior change (23) and that it is 
cost-effective (24). 
The current trial adopted behavior change strategies underpinned by Social Cognitive 
Theory (SCT)(25), specifically developing knowledge and skills related to the SCT 
construct of self-efficacy. Participants were encouraged to set small, measurable and 
achievable physical activity goals to facilitate a sense of confidence and mastery that 
was built upon as physical activity levels were progressed throughout the intervention. 
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Exercise for Health-rural (EfH) was a pragmatic trial that evaluated the feasibility and 
effectiveness of a telephone-delivered exercise intervention, beginning soon after 
surgery, and targeting women with breast cancer residing in regional and rural 
Queensland, Australia. 
Methods 
Study Design 
A randomised controlled trial was conducted, evaluating an eight-month mixed (aerobic 
and resistance training) exercise intervention delivered via telephone by tertiary- 
qualified Exercise Physiologists, commencing six weeks post-surgery for newly 
diagnosed breast cancer patients, compared to usual care. Assessments occurred at 
baseline, 6-months and 12-months post-surgery (see Figure 1 in the Electronic 
Supplementary Material). Primary outcomes were feasibility indicators (recruitment and 
retention rates, sample representativeness, intervention implementation and participant 
satisfaction). Secondary effectiveness outcomes were meeting intervention targets for 
aerobic and resistance training, quality of life, fatigue, anxiety and upper body function. 
The trial was reviewed and approved by the Ethics Committee at The University of 
Queensland and at each of the participating hospitals. Data were collected from April 
2007 to April 2009 with analysis from February to October 2010. Trial protocol is 
available from the corresponding author. EfH-rural was run concurrently with a larger, 
urban trial that evaluated a telephone-delivered exercise intervention arm and a face-to- 
face arm, compared to usual care (26). 
Eligibility criteria 
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Women with a first diagnosis of invasive breast cancer aged 20 to 69 years, treated at 
one of eight regional, or four large metropolitan, Queensland hospitals and residing 
within a postal code considered inner regional, outer regional, remote or very remote 
according to the Australian Standard Geographical Classification (27) were eligible for 
participation. Women were excluded for: pregnancy or lactation, plans for additional 
surgery (e.g., breast reconstruction) during the study period, and medical conditions that 
would prohibit participation in the home-based exercise intervention (e.g., unstable 
hypertension). 
Participant Recruitment 
Breast Care Nurses at the participating hospitals were asked to approach all women 
receiving surgery for breast cancer to ascertain consent for researcher contact. 
Research assistants called potential participants 3-4 weeks post-surgery to explain the 
trial, screen for eligibility and obtain informed consent. 
Randomization 
Following baseline assessment, the project manager randomized women, individually to 
the intervention (Tel, n=73) or usual-care (UC, n=70) group via a computer-generated, 
unblocked, sequence of random numbers. 
Telephone-Delivered Exercise Intervention 
The intervention, described in detail elsewhere (26), involved 16 calls of 15-30 minutes 
duration over eight months (once/week for 2 months, once/fortnight for 2 months and 
once/month for 4 months) delivered by an Exercise Physiologist (EP). The intervention 
was underpinned by SCT (25), with an emphasis on increasing women’s self-efficacy 
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for exercise, and was implemented according to the Chronic Disease Self-Management 
Intervention Model adapted from our previous trials (28, 29). Each session assessed 
exercise progression during the previous period and ascertained any presence or 
change in treatment-related symptoms. Exercise achievements were acknowledged, 
barriers resolved, subsequent behaviourally-specific exercise goals agreed upon, 
continued self-monitoring of exercise was encouraged, and necessary follow-up support 
identified. The intervention target for all women was to exercise at least four days per 
week, for at least 45 minutes, including aerobic-based (moderate-to-vigorous intensity) 
exercise (such as brisk walking) each session, as well as strength-based exercise at 
least twice per week (4). However, the exercise starting parameters and rate of 
progression were individualised according to baseline functional capacity, treatment- 
related side-effects, exercise preferences and previous exercise history, with women 
gradually building up to these targets. When a woman was not reached for a call, 
multiple call-back attempts were allowed to encourage maximum participation. EPs had 
undergraduate degrees in exercise physiology and completed three weeks of study- 
specific training. EPs met weekly to fortnightly with study investigators for clinical 
supervision related to intervention delivery. 
Study workbook and exercise tracker 
An exercise workbook (available on request), developed by the study investigators, was 
provided to all intervention participants and used during telephone sessions. It 
contained information on treatment-related side-effects, benefits of being active during 
treatment, exercise safety, types, frequency and intensity of activity and how to 
progress exercise. It also depicted several strength and flexibility-based exercises. EPs 
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explained these exercises and encouraged women to check for correct technique in the 
mirror. A weekly exercise tracker was provided to promote self-monitoring. 
Usual care group 
Women in the UC group participated in all study assessments but had no intervention 
contacts. The workbook and exercise tracker were mailed to UC participants following 
study completion. 
Data Collection 
Breast Care Nurses in each participating hospital recorded the number of women 
approached. Representativeness was established by comparing data obtained from the 
Queensland Cancer Registry (QCR) for the EfH sample with the same data for the 1488 
breast cancers diagnosed in 2007 among women from non-urban postcodes. Call 
completion and adverse events were recorded by EPs in case management folders 
after each call for those in the Tel group. 
Data were collected by telephone interviews (for physical activity) and postal 
questionnaires (demographics, treatment, quality of life, fatigue, anxiety and upper body 
function). Further treatment and pathology data were obtained from the QCR for most 
extensive surgery, stage, type of cancer, lymph node status, tumor size and tumor 
grading. Data collections were scheduled at: baseline/5-6 weeks post-surgery (pre- 
intervention); six months post-surgery (mid-intervention and following the period of more 
regular contact with the EP for those in the Tel group); and, 12 months post-surgery 
(approximately two months post-intervention) (Figure 1). These timepoints coincide with 
the endpoints from our recent prospective cohort study (11). On average, the 
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assessments occurred close to the scheduled times, however there was some 
variability in the time between assessments, much of which was due to variation in how 
soon baseline data collection occurred after surgery. 
Measures – Patient-Reported Outcomes 
Physical activity was assessed by the Active Australia Survey (AAS), which has been 
reported as reliable and has acceptable validity with the Australian adult population (30); 
is responsive to change following intervention (31) and has been used with Australian 
cancer patients (10, 32, 33); and in our previous trials (21, 29). Total minutes of physical 
activity was calculated from the sum of walking, moderate and 2 × vigorous minutes and 
truncated at 1,680 minutes per week (30). Strength training was assessed via CHAMPS 
(Community Healthy Activities Models Programs for Seniors), a reliable, valid and 
responsive instrument aimed at older adults (34, 35), which has also been used in 
cancer patients (19, 36). The primary study outcomes were meeting EfH targets for 
aerobic activity (>4 times/wk and >180 minutes of moderate-to-vigorous activity) and 
resistance training (>2 sessions/wk). 
Quality of life was assessed using the Functional Assessment of Cancer Therapy – 
Breast (FACT-B+4) questionnaire (37). Fatigue was measured using the FACIT 
(Functional Assessment of Chronic Illness Therapy) - Fatigue Scale (38). These 
instruments have been widely used in cancer research and have excellent reliability and 
validity (37-39). Internal consistency was high for both these measures (Cronbach’s α = 
0.89, 0.94, respectively). State anxiety was measured using the six-item State Trait 
Anxiety Inventory (STAI-Sf), which has good reliability and validity (40) (Cronbach’s α = 
0.86). Subjective upper body function was assessed using the Disability of Arm, 
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Shoulder and Hand (DASH) questionnaire (41), which has been used for breast cancer 
patients (42-44) (Cronbach’s α = 0.95). Confidence to exercise (self-efficacy) was 
assessed via 6-items on a 5-point Likert scale adapted from a valid and reliable scale 
(45) and had acceptable internal consistency (Cronbach’s α = 0.83). 
A study-specific evaluation questionnaire was administered to the Tel group. Three 
items asked about how helpful the program and its resources had been in recovery from 
breast cancer (1 = “very unhelpful” to 7 = “very helpful”). Two items covered interest in 
program delivery via face to face and via the internet (1 = “much less interested” to 7 = 
“much more interested”). 
Higher scores indicate better (FACT-B+4, fatigue) or worse (anxiety, DASH) health. 
Minimum differences of interest on our primary effectiveness outcomes, based on 
published evidence where available and convention where not, were: 10% for physical 
activity targets, 8 points for quality of life (37), 3 for fatigue (39), half a standard 
deviation (here, 7.8 points) for anxiety (46) and 10% of the baseline mean (here, 2.2 
points) for DASH (42). 
Statistical analysis 
The sample size (n=143) was based on available resources. It provides 80% power (5% 
significance, two-tailed) to detect between-groups differences of: 30% in meeting EfH 
aerobic activity and resistance training targets, 8 points for FACT-B+4, 6 for fatigue, 8 
for anxiety and 7 for DASH. Significance was set at p<0.05 (two-tailed). 
Mixed models were used, with random intercepts for each individual and for each 
hospital, to accommodate repeated measures without requiring complete case analysis 
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(47) and to correct for clustering within hospitals. Physical activity data did not conform 
to any distribution that could be modeled continuously; hence, we examined categorical 
outcomes with a binomial distribution and logit link. Quality of life, fatigue, anxiety and 
DASH were examined continuously as change scores (i.e. 6-month value minus 
baseline value), as change scores approximated a normal distribution, using models 
that assumed a normal distribution. All models adjust for baseline values of the outcome 
(to control possible regression to the mean) and, if significant at p<0.2, for time between 
surgery and baseline (weeks), and any other variable that was meaningfully imbalanced 
(i.e. by ≥10%) between groups at baseline, or any treatment-related variable that was 
imbalanced between groups over the course of the program. 
Analyses were intention-to-treat, however, missing /invalid values were not imputed 
using baseline carried forward or last-value carried forward methods as the assumption 
of no change is not realistic over a period of fluctuating recovery from breast cancer. 
The data appeared to be missing completely at random, as there was no association 
between observed characteristics and the likelihood of data being missing (data not 
shown). 
Mediational analysis (48) was used to examine whether intervention effects on physical 
activity and resistance training (minutes and sessions per week) were mediated by 
changes in confidence to exercise, as measured on a 6-item scale, scored from 1 
(lowest) to 5 (highest) (45). 
Results 
Feasibility 
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Recruitment rate: Over 14 months of recruitment (March 2007 – April 2008), 383 
women were approached for trial participation; 234 were deemed eligible, of whom 143 
(61%) consented to participate (Figure 2). Refusal did not vary by hospital and eligible 
women who refused were of a similar age to participating women (mean (SD): 53.6 
(8.7) vs 52.9 (8.9) years, p=0.69). 
Retention: Retention was 97% at 6 months and 96% at 12 months, with only 5 Tel and 
1 UC participant withdrawing from the study (p=0.209 for group difference in 
withdrawal). 
Figure 1 About Here 
Sample Characteristics and Representativeness: The sample of women, diagnosed 
between November 2006 and April 2008, was aged 29 to 69 years, with 34.3% being 
overweight and 25.2% obese (Table 1). Just over half of participants had less than high 
school education and most were not working at the time of study entry. The majority of 
the sample received one or more adjuvant therapies (chemotherapy, 64%; radiation, 
63%; hormone therapy, 66%) before or (mostly) during the trial. The study sample was 
slightly younger, but similar in terms of disease characteristics (i.e., tumor size, number 
of positive nodes, histological type) to non-urban women diagnosed with breast cancer 
in Queensland in 2007 (see Table 1 in the Electronic Supplementary Material). 
Intervention Implementation: Tel group participants who remained in the program 
completed a median of 14/16 calls with their EP (from 5 to 16); 79% completed the 
majority (>75%) of calls. In total, three adverse events were reported that may be 
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related to exercise intervention participation (muscle soreness (n=2), musculoskeletal 
injury (n=1); none were serious and none required discontinuation of participation. 
Participant satisfaction 
The majority of Tel group participants rated the EfH program, workbook, and telephone 
sessions with the EP as “helpful” to “very helpful” in their breast cancer recovery (90%, 
89%, and 92%, respectively). The majority of participants also reported that they would 
have been at least “interested” in the EfH program if it had been delivered via face-to- 
face (83%) and over the internet (76%). 
Effectiveness 
There was no evidence of failure of randomization (i.e. all baseline group differences 
were p>0.05), however there were some notable group differences (>=10%) in terms of 
income (<$52,000 per annum), receipt of radiotherapy at baseline, overall receipt of 
chemotherapy, surgery type and lymph node status. 
Physical Activity 
Table 2 presents participants’ physical activity at each assessment. Meeting program 
targets was more common, and doing no activity was less common, for the Tel 
compared with the UC group at both follow-up assessments. Only results for resistance 
training reached statistical significance. Observing the percentages achieving each 
outcome at each time point, for the Tel group, the most improvement occurred by six- 
months post-surgery; for the UC group, improvements only occurred by 12-months 
post-surgery. 
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Mediational analysis (see Table 2 in the Electronic Supplementary Material) showed no 
statistically significant effect of the intervention on physical activity or strength training 
mediated by confidence to exercise. Confidence to exercise increased significantly 
more for intervention than control groups at only 6-months post surgery (by 0.3 points). 
Increases in confidence between baseline and 12-months post surgery were associated 
with increases in physical activity over the same period: 1.1 sessions per week 
(significant); and, nearly one hour per week (only significant at p<0.1).Other 
associations were mostly positive in direction, but small and not statistically significant. 
Quality of Life, Fatigue, Anxiety, Upper Body Function 
Table 3 presents participants’ baseline values and adjusted mean changes in outcomes 
from baseline to follow-up. Improvements in outcomes were all larger in the Tel than the 
UC group, however, none of the comparisons were statistically significant and only the 
12-month group difference in upper body function was of a meaningful magnitude. Only 
upper body function improved significantly or meaningfully between baseline and six- 
months post-surgery. Significant improvements were seen by 12-months post-surgery in 
all outcomes within the Tel group, and in all outcomes except anxiety within the UC 
group. The amount of change was meaningful in quality of life (Tel only), fatigue, and 
upper body function. 
Discussion 
Despite recruitment occurring during a very challenging part of the cancer treatment 
trajectory, results from our trial suggest that a focus on promoting physical activity as 
part of breast cancer recovery soon after surgery holds strong appeal and is feasible to 
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deliver via telephone to women living outside urban areas. The trial had high 
participation and very high 12-month retention rates; participant satisfaction ratings 
were very high; no serious adverse events were reported; and, the majority of Tel group 
participants completed most of the scheduled calls. Our results are somewhat 
consistent with previous trials of non-face-to-face exercise interventions during adjuvant 
treatment (13-15) in that retention at six-months is consistently high: 80% (15), 88% 
(13), and 90% (14). However, consent rates are variable: 15% (14), 33% (15), and 88% 
(13). 
Effectiveness results were more modest. A statistically significant between-groups effect 
of the program was only seen for resistance training. While not conclusive, examination 
of within-groups changes suggested a pattern of earlier recovery in terms of physical 
activity outcomes for women in the Tel group. Observing the percentages achieving 
each outcome at each time point, for the Tel group, the most improvement occurred by 
six-months post-surgery; for the UC group, improvements only occurred by 12-months 
post-surgery. While there were no significant intervention effects mediated by 
confidence to exercise, results should be interpreted cautiously as the total intervention 
effects were modest to begin with, the mediational analyses were exploratory (not 
powered a priori) and may have been affected by non-normality of the data. 
All outcomes except anxiety showed some improvement in the UC group, which 
contributed to the lack of difference between groups. The reasons for the UC 
improvements are unclear. Such change would be expected for some outcomes (e.g. 
quality of life) from the usual recovery trajectories (49). Quality of life improvements 
between six- and 12-months post-surgery (7.6 points in Tel, 5.5 points in UC) were 
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similar to improvements over this period in the Australian Pulling Through Study (PTS) 
cohort study (49). For physical activity, however, normative data suggests no change 
over the six- to 12-month post-surgical period (11). Although we did not see biased non- 
participation, possibly the sample were a more motivated group than the broader 
population (which we could not assess). 
The lack of intervention effects on other patient-reported outcomes (i.e., quality of life, 
fatigue, anxiety and upper body function) is likely partly attributable to the small and 
non-significant improvements in aerobic activity. Especially for quality of life, ceiling 
effects may also have hampered intervention outcomes, as our sample had higher than 
expected scores at baseline; at 12-months post surgery, both Tel and UC participants 
had higher average quality of life compared to published data on non-urban Queensland 
women with breast cancer (data not shown) (50). 
In the trial with outcomes most comparable to ours, Cadmus and colleagues reported 
no intervention effect on self-reported physical activity or quality of life (FACT-B) (14). 
For these outcomes, they concluded, as have we, that high baseline levels reduced the 
ability to demonstrate a treatment effect. Schwartz et al (13) found an effect on 
preservation of bone mineral density, aerobic capacity and muscle strength, but quality 
of life was not reported. Segal et al (15) found a treatment effect on their primary 
outcome of physical function (measured by the SF-36 (51)), but not for overall quality of 
life (SF-36 and FACT-B), and no effect on aerobic capacity or weight. The authors (15) 
suggested that the FACT-B may lack sensitivity to change in exercise intervention trials. 
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Ours is the first study to evaluate an exercise intervention begun soon after breast 
cancer surgery that targets women living outside of major metropolitan areas (an 
understudied group). Retention was high, and drop-out did not appear to be systematic; 
hence, results are likely to be minimally affected by non-response bias. The timing of 
study assessments allowed comparison with normative data, but did not coincide 
exactly with the end of intervention (the usual trial endpoint). The use of self-report 
measures of physical activity, known to be subject to over-reporting (52), is also a 
limitation. 
Future trials would do well to consider use of objective measurement of physical activity, 
longer-term follow-ups to address the important issue of maintenance, as well as 
inclusion of cost-effectiveness analysis. As suggested by women in this trial, other non- 
face-to-face means of intervention delivery (e.g. Internet) should also be investigated. 
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Figure Legend 
Figure 1 - Flow chart of participant recruitment and retention 
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Table 1. Baseline characteristics of participants in the Exercise for Health Trial (n=143) 
TC (n=73) 
Age (yrs), mean (SD) 
BMI (kg/m ), mean (SD) 
Income 
   <$52,000 
$52,000 - $93,599 
$93,600 - $130,000+ 
Education n (%) > Year 12 
Currently working 
   No 
   Full-time 
   Part-time/casual/other 
Living arrangements 
   Alone or with children/relatives/friends 
Couple with no children 
Couple with children 
Treatment and Disease Characteristics 
Chemotherapy (Baseline / Any) 
   Yes 
No 
Radiotherapy (Baseline / Any) 
  Yes 
  No 
Hormone Therapy (Baseline / Any) 
  Yes 
  No 
Herceptin (Baseline / Any) 
  Yes 
  No 
Most extensive surgery 
  Lumpectomy 
  Mastectomy 
Cancer Stage 
  0/I 
  II + 
Type of Cancer 
  Infiltrating ductal 
  Infiltrating lobular 
  Mixed ductal/lobular 
  Carcinoma In-situ 
  4 (5.5) / 42 (57.5) 
69 (94.5) / 26 (35.6) 
11 (15.1) / 47 (64.4) 
62 (84.9) / 23 (31.5) 
 2 (2.7) / 12 (16.4) 
71 (97.3) / 55 (75.3) 
29 (39.7) 
39 (53.4) 
26 (35.6) 
38 (52.1) 
55 (75.3) 
 3 (4.1) 
 3 (4.1) 
 2 (2.7) 
11 (15.7) / 43 (61.4) 
59 (84.3) / 23 (32.9) 
9 (12.9) / 41 (58.6) 
61 (87.1) / 23 (32.9) 
 2 (2.9) / 7 (10.0) 
68 (97.1) / 56 (80.0) 
37 (52.9) 
30 (42.9) 
31 (44.3) 
32 (45.7) 
49 (70.0) 
 9 (12.9) 
 2 (2.9) 
 1 (1.4) 
a 
2 
UC(n=70) 
54.1 (8.7) 
27.7 (7.8) 
43 (61.4) 
13 (18.6) 
 5 (7.1) 
32 (45.7) 
46 (65.7) 
10 (14.3) 
13 (18.6) 
17 (24.3) 
33 (47.1) 
20 (28.6) 
51.7 (9.0) 
26.8 (5.4) 
36 (49.3) 
22 (30.1) 
 7 (9.6) 
35 (47.9) 
49 (67.1) 
11 (15.1) 
13 (17.8) 
18 (24.7) 
33 (45.2) 
22 (30.1) 
27 (37.0) /49 (67.1) 
46 (63.0) / 20 (27.4) 
21 (30.0) /37 (52.9) 
49 (70.0) / 29 (41.4) 
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Other invasive carcinoma 
Lymph Node Status 
  negative 
  positive 
  none removed 
Tumor Size, Mean (SD) 
Tumor Grading -Overall Histological Grade 
  Grade 1 
Grade 2 
Grade 3 
4 (5.5) 
34 (46.6) 
30 (41.1) 
 3 (4.1) 
24.6 (20.3) 
10 (13.7) 
28 (38.4) 
26 (35.6) 
5 (7.1) 
42 (60.0) 
22 (31.4) 
 1 (1.4) 
23.8 (18.8) 
7 (10.0) 
33 (47.1) 
23 (32.9) 
Table presents Mean (SD) or N (%). Figures sum to N<73 (TC)/ 70 (UC) and <100% 
where data are missing. 
a In those completing the questionnaires, item non-response regarding chemotherapy, 
radiotherapy, hormone and herceptin, is assumed to reflect no treatment. Participants 
classed as “missing” are those who never reported the treatment and did not return at 
least one follow-up questionnaire. 
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Table 2. Adjusted odds of physical activity outcomes for telephone counseling (Tel) 
versus usual care (UC) participants 
% (Unadjusted) 
  Tel 
(N=68) a 
Four or more sessions 
AND at least 180 min/wk 
of moderate-to- 
vigorous physical 
activity (MVPA) 
Two or more sessions 
of strength training per 
weekc 
Baseline 
Six months post surgery 
Twelve months post 
surgery 
Baseline 
Six months post surgery 
Twelve months post 
surgery 
22.1 
41.2 
52.2 
  UC 
(N=67)a 
31.3 
29.9 
40.3 
  Tel vs UC 
Adjusted OR b 
  (95% CI) 
2.1 (0.8, 5.6) 
2.1 (0.8, 5.5) 
5.9 
45.6 
40.3 
 9.0 
10.4 
17.9 
       - 
8.2 (2.6, 25.3)* 
3.2 (1.2, 8.9)* 
a n with data on covariates and outcomes at one or more follow-ups. N=68 Tel, N=67 
UC for 6-month estimates N=67 Tel, N=67 UC for 12-month estimates 
*p<0.05 
b Mixed models (binomial distribution, logit link) include random intercepts for person 
and hospital. Odds ratios are adjusted for baseline values of the outcome (all models) 
and: time between surgery and baseline (weeks), age, baseline radiotherapy (yes/ no or 
unknown), any prior chemotherapy (yes/ no or unknown), surgery (mastectomy/ 
lumpectomy) [Physical Activity Targets]; time between surgery and baseline, age, 
baseline radiotherapy, surgery (mastectomy/ lumpectomy) [Strength Targets]. 
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Table 3. Baseline values and adjusted a mean change from baseline in continuous outcomes at 6- and 12-months post 
surgery among telephone counselling (Tel) and usual care (UC) participants 
Tel (n=73) 
   Mean 
 (SD, SE) 
Quality of life 
              b 
(FACTB +4) 
(0 to 160) 
Fatigue 
         b 
(FACIT) 
(0 to52) 
Anxiety 
(STAI) b 
(20 to 80) 
Baseline: mean (SD) 
6-months: mean change (SE) 
12-months: mean change (SE) 
118.5 (18.0) 
  3.1 (1.7) 
 10.7 (1.7)*** 
UC (n=70) 
   Mean 
 (SD, SE) 
121.0 (19.4) 
  1.6 (1.8) 
  7.0 (1.8)*** 
    Tel-UC 
Mean difference 
   (95%CI) 
       - 
1.5 (-3.6, 6.6) 
3.7 (-1.5, 8.9) 
n 
68 
68 
66 
n 
64 
63 
60 
p 
0.549 
0.156 
Baseline: mean (SD) 
6-months: mean change (SE) 
12-months: mean change (SE) 
Baseline: median (25th, 75th) 
6-months: mean change (SE) 
12-months: mean change (SE) 
th th 
36.8 (10.7) 
 1.2 (1.1) 
 5.6 (1.1)*** 
40.0 (33.3, 51.7) 
    -3.1 (1.7) 
    -7.2 (1.7)*** 
68 
68 
66 
68 
66 
64 
35.2 (12.1) 
-0.8 (1.2) 
 3.7 (1.2)** 
36.7 (26.7, 46.7) 
    -2.8 (1.7) 
    -2.1 (1.8) 
63 
63 
59 
62 
62 
55 
       - 
2.0 (-1.4, 5.3) 
1.9 (-1.5, 5.3) 
        - 
-0.3 (-5.2, 4.6) 
-5.1 (-10.1, +0.0) 
0.233 
0.259 
0.891 
0.050 
Function 
(DASH) b 
 (0 to 100) 
Baseline: median (25 , 75 ) 
6-months: mean change (SE) 
12-months: mean change (SE) 
21.7 (7.5, 31.7) 
    8.7 (1.2)*** 
  -11.7 (1.2)*** 
69 
69 
67 
18.3 (17.5, 29.6) 
    -8.5 (1.2)*** 
    -8.9 (1.2)*** 
64 
64 
60 
         - 
-0.21 (-3.7, 3.3) 
 -2.9 (-6.4, 0.7) 0.902 0.107 
Table presents mean (SD) at baseline, and adjusted mean change from baseline (SE) at 6-months and 12-months post 
surgery 
* p<0.05 ** p<0.01 *** p<0.001 
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a Mixed models included random intercepts for person and hospital. 6-month and 12-month data are adjusted for baseline 
values (all models) and: surgery (mastectomy/lumpectomy), lymph node status (postive/ negative or unkown) [FACTB+4]; 
surgery type, lymph node status [Fatigue]; baseline radiotherapy, income (<$52, 000 p.a. / 52, 000+ p.a. / missing) 
[Anxiety]; time between surgery and baseline (weeks), age, baseline radiotherapy (yes/ no or unkown), previous 
chemotherapy (yes/ no or unkown) [DASH]. 
b Higher scores indicate: higher quality of life (FACTB+4), less fatigue (FACIT), more anxiety (STAI) and poorer upper 
body function (DASH). 
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28 
29 
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31 
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33 
34 
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38 
39 
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41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
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Assessed for eligibility 
     (n = 383) 
Enrolment 
(n = 155) 
Ineligible (n = 149) 
Reasons: outside age range (n = 98); not first breast 
cancer diagnosis (n = 22); additional surgery planned (n = 
11); living in or moving to major city (n = 8); greater than 
12 months post surgery (n = 4); other (cognitive difficulties, 
limited English, drug and alcohol problems) (n = 6) 
Refused to participate (n = 79) 
Reasons: health and medical concerns (n = 36); difficult to 
contact (n = 8); not interested (n = 15); no reason given (n 
= 12); other (recovered, limited English/writing skills; family 
commitments, involved in another study) (n = 8) 
.... 
Withdrew prior to baseline testing (n = 12) 
Reasons: going overseas (n = 2); medical/family issues (n 
= 2); questionnaire not returned (n = 6); personal reasons 
(n = 2) 
     Baseline assessment (n = 143) 
             No withdrawals 
Random allocation after baseline assessment 
Telephone (n = 73) 
Withdrew (n = 4)* Reasons: 
health concerns 
Usual Care (n = 70) 
Withdrew (n = 1) Reasons: 
health concerns 
6-months post-surgery assessment 
Telephone (n = 70) 
Assessments: 
Telephone interviews (n = 70) 
Postal survey (n = 69) 
Usual Care (n = 69) 
Assessments: 
Telephone Interviews (n = 69) 
Postal survey (n = 66) 
Withdrew (n = 1) 
Reason: no longer has cancer 
No Withdrawals 
12-months post-surgery assessment 
Telephone (n = 68) 
Assessments: 
Telephone interviews (n = 68) 
Postal survey (n = 67) 
Usual Care (n = 69) 
Assessments: 
Telephone Interviews (n = 69) 
Postal survey (n = 63) 
* 3 withdrew prior to both 6-month assessments; 1 withdrew after the 6-month 
telephone interview but before the 6-month postal questionnaire 
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Figure 
Figure 1- Study design/timeline 
BC = breast cancer; PS = post-surgery 
Table 
Table 1: Baseline demographic and disease characteristics of Exercise for Health study 
participants (n=143) diagnosed between 2006 and 2008 compared with Queensland 
Cancer Registry data for breast cancers diagnosed among non-urban women in 2007 
(n=1488) 
Age at diagnosis (years) 
Breast cancer size (mm) a 
Number of nodes examined a 
Positive nodes (%)a 
Histological type a 
  Infiltrating ductal100 (75.8) 
  Infiltrating lobular9 (7.1) 
  Other23 (17.1) 
                          thth 
Table presents median (25 , 75 percentile) or N (%) 
Study Participants 
   53 (46, 60) 
   15 (10, 30) 
    10 (5, 15) 
    44 (33.1) 
Cancer Registry 
  59 (50,68) 
  16 (10, 27) 
   8 (2, 14) 
  479 (34.7) 
1072 (72.0) 
 153 (10.3) 
 263 (17.7) 
Source: Queensland Cancer Registry Data Collection, extracted 24-01-11. 
a Study data are weighted to the age distribution of non-urban Queensland breast 
cancer cases 
b % excludes women of ‘unknown’ node status / histological type. 
 Table 2. Mediation a of intervention changes in physical activity outcomes at 6- and 12- months by concurrent changes in 
confidence to exercisea 
6- month changes (n=70 Tel; n=69 UC) 
      β (SE)β (95% CI) 
   abab 
Physical Activity 
            Minutes / week 
           Sessions / week 
Strength training 
            Minutes / week 
           Sessions / week 
0.3(0.1)* 
0.3(0.1)* 
0.3(0.1)* 
0.3 (0.1)* 
7.5(18.5) 
-0.2 (0.4) 
10.9 (8.1) 
 0.3(0.3) 
2.5 (-6.9, 18.5) 
 0.1 (-0.5, 0.3) 
3.7 (-0.4, 16.7) 
 0.1 (-0.0, 0.4) 
12-month changes (n=68 Tel; n=69 UC) 
     β (SE)β (95% CI) 
 abab 
0.1(0.1) 
0.1 (0.5) 
0.1 (0.1) 
0.1 (0.1) 
57.9 (30.7)^ 
 1.1 (0.5)* 
8.9 (5.6) 
0.4 (0.3) 
3.0(-11.6, 25.5) 
 0.1 (-0.2, 0.5) 
 0.5 (-1.6, 4.9) 
+0.0 (-0.1, 0.2) 
a Mediated effect (ab) with bootstrapped 95% confidence intervals (n=5000 iterations). Models adjust for baseline values 
of the relevant physical activity measures. The a pathway is the group difference (Tel – UC) in changes in confidence to 
exercise (adjusted for baseline values); the b pathway is the association between changes in confidence and changes in 
physical activity outcomes (adjusted for group and baseline values). 
b Confidence to exercise (1-6) (48). Mean (SD) at baseline, 6-months and 12-months were: 3.7(1.0), 4.3(0.6), 4.4 (0.6) 
[Tel] and 3.6(0.9), 3.8(0.7), 4.0(0.8) [UC] for those with complete data (n=68 Tel; n=69 UC). 
*p<0.05 ^p<0.1 
